123 results
Page 4 of 7
8-K
EX-10.3
mdyhz cy7cyjq
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
gwqhr2zx303aq0
24 Jun 20
Business combination disclosure
4:03pm
425
va45i446qgzfu67xc
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.4
p99w4nhjhg1pv
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.2
o69wvheblb ohv2rj
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
wbbkk4e xd
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
8-K
EX-1.1
s8wxv9q570 98wa6
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-99.2
ziosfbfo2lca0r
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
7wn9nt2nm
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
yo2bz uhjka
19 Feb 20
Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019
4:08pm
8-K
EX-99.1
odu o60701
13 Jan 20
Results of Operations and Financial Condition
5:11pm
8-K
EX-99.1
9bwrxa07jzee
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K/A
EX-99.2
q0ff815y
27 Sep 19
Financial Statements and Exhibits
4:16pm
8-K/A
EX-99.1
qeo7 3r63c
27 Sep 19
Financial Statements and Exhibits
4:16pm